Home Research Research themes Health consequences of climate change Protocols PR12009

PR12009

A randomised, double-blind, double-dummy, active-comparator controlled study investigating the efficacy and safety of linagliptin co-administered with metformin QD at evening time versus metformin BID over 14 weeks in treatment naive patients with type 2 diabetes mellitus and insufficient glycaemic control
Short Title Linagliptin in type 2 diabetes mellitus
Protocol No PR12009
Status Completed
Keywords LINAGLIPTIN, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, TYPE 2 DIABETES MELLITUS, INSUFFICIENT GLYCAEMIC CONTROL
Center Vaccine Sciences
MDG(s) this protocol relates to Global Partnership;
HPNSDP(s) this protocol relates to Improving health;
PI Name Rubhana Raqib
Collaborating Institutes (008) Bangabandhu Sk. Mujib Medical University and Hospital, Dhaka
(012) Bangladesh Institute of Research and Rehabilitation in Diabetes,
(363) Bangladesh Medical College Hospital, Dhaka
Funding
Summary
‹ Search All Protocols Here